Monica Gonzalez, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 3035 N Main St, Soquel, CA 95073 Phone: 831-465-8680 Fax: 831-465-8681 |
Suzanne Kent, Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 2645 Old San Jose Rd, Soquel, CA 95073 Phone: 831-477-9069 |
Cynthia Quattro, Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 3121 Park Ave Ste H, Soquel, CA 95073 Phone: 831-427-5311 |
Laura Melany Yassa, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 4439 Esta Ln, Soquel, CA 95073 Phone: 831-419-1309 |
Mr. Michael Robert Morley, MPA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 3035 N. Main Street, Soquel, CA 95073 Phone: 831-688-8680 Fax: 831-661-0136 |
Matthew Lowe, Physician Assistant Medicare: Medicare Enrolled Practice Location: 4700 Soquel Dr, Soquel, CA 95073 Phone: 831-888-9410 Fax: 831-477-7795 |
Biena Kawasaki Culligan, Physician Assistant Medicare: Medicare Enrolled Practice Location: 2950 Research Park Dr, Soquel, CA 95073 Phone: 831-458-6272 |
News Archive
Triple-negative breast cancer is an aggressive cancer, one that's likely to recur and to metastasize.
In the U.S. Department of State's DipNote blog, David Lane, U.S. ambassador to the U.N. food and agriculture agencies in Rome, writes about hosting a media tour for journalists, to provide them "an opportunity to see how countries like Tanzania and Malawi are investing in agriculture and in programs to fight hunger and improve nutrition, and how development partners like the United Nations and United States are helping them.
Cerapedics, a privately-held orthobiologics company, announced today results from a pivotal FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR Peptide Enhanced Bone Graft in anterior cervical discectomy and fusion (ACDF) procedures have been electronically published in the peer-reviewed journal Spine.
The International Association for the Study of Lung Cancer commends the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval for osimertinib (Tagrisso), an oral medication for advanced non-small cell lung cancer (NSCLC) patients with a specific epidermal growth factor receptor (EGFR) mutation (T790M) and following progression after previous EGFR inhibitor therapies.
Research is leading to new insights on two major public health challenges: preventing the spread of sexually transmitted infections (STIs) and improving disease control for patients with type 2 diabetes. Expert updates on these critical topics appear in a special symposium section of the January issue of The American Journal of the Medical Sciences (The AJMS), official journal of the Southern Society for Clinical Investigation.
› Verified 9 days ago